Internal Medicine Alert – May 15, 2009
May 15, 2009
View Issues
-
Is One Statin Pill a Week Enough?
Once-a-week rosuvastatin therapy was well tolerated in patients with a history of adverse events to one or more statins and led to significantly improved lipoprotein changes. -
No Clarity for Cholecystectomy
We don't have the slightest idea whether evidence of gallbladder dyskinesia should warrant cholecystectomy or not. -
The Buck Stops with Discharge Planning
Almost one-fifth of Medicare patients who were discharged from a hospital were rehospitalized within 30 days, and about a third were rehospitalized within 90 days. Most of these readmissions were not planned. -
Everolimus Tablets (Afinitor®)
Everolimus is the newest oral kinase inhibitor approved for the treatment of advanced renal cell carcinoma. -
Clinical Briefs By Louis Kuritzky, MD
The ACCORD trial has been newsworthy in the last several months primarily due to the early results of increased cardiovascular events associated with very tight glucose control. -
ECG Review: Flutterfact
The simultaneously obtained lead II and lead V1 rhythm strip seen above was interpreted as showing atrial fibrillation with a rapid ventricular response. Do you agree?